Loading clinical trials...
Loading clinical trials...
Use of Response-Adapted Hypofractionated Radiation Therapy to Potentiate the Systemic Immune Response to Checkpoint Inhibitors in Non-Small Cell Lung Cancer
Conditions
Interventions
Radiation
Immuno-Therapeutic Agent
Locations
1
United States
WVU Cancer Institute - Mary Babb Randolph Cancer Center
Morgantown, West Virginia, United States
Start Date
January 23, 2017
Primary Completion Date
June 30, 2022
Completion Date
June 30, 2022
Last Updated
April 1, 2025
NCT06917573
NCT03774732
NCT03808662
NCT05117242
NCT03907852
NCT03307785
Lead Sponsor
West Virginia University
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions